Related Experiment Video
Updated: Jul 7, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Plant stanol ester consumption and arterial elasticity and endothelial function
Olli T Raitakari1, Pia Salo, Helena Gylling
1Department of Clinical Physiology, University of Turku, Turku, Finland.
Plant stanol esters lowered LDL-cholesterol but did not significantly improve overall arterial health markers like carotid artery compliance (CAC) or endothelial function (FMD) in adults. Further studies are needed for individuals with initially reduced arterial elasticity.
Area of Science:
- Cardiovascular Health
- Nutritional Science
- Medical Research
Background:
- Elevated serum cholesterol is a risk factor for cardiovascular disease.
- Plant stanol esters are known to reduce LDL-cholesterol.
- The impact of plant stanol esters on arterial elasticity and endothelial function requires further investigation.
Purpose of the Study:
- To evaluate the effect of plant stanol esters in different vegetable oil spreads on arterial health.
- To assess changes in carotid artery compliance (CAC) and brachial artery flow-mediated endothelial dependent vasodilatation (FMD).
Main Methods:
- Randomized controlled trial involving 200 adults with high serum cholesterol.
- Intervention groups consumed stanol ester-enriched spreads (camelina, rapeseed, or sunflower oil) for 3 months.
- Non-invasive ultrasound measured CAC and FMD at baseline and post-intervention.
Main Results:
- Plant stanol esters significantly reduced LDL-cholesterol by 9% compared to controls.
- No significant overall changes in CAC or FMD were observed in the combined treatment groups.
- Subgroup analysis indicated potential improvements in CAC and FMD among individuals with initially low arterial elasticity.
Conclusions:
- Consumption of plant stanol esters for 3 months did not demonstrate significant overall improvements in arterial elasticity and endothelial function.
- Beneficial effects may be specific to individuals with pre-existing reduced arterial health.
- Further controlled studies are recommended to confirm these subgroup findings.
Related Concept Videos
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Atherosclerosis I: Introduction
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...

